HURA — TuHURA Biosciences Share News
0.000.00%
Last trade - 00:00- $131.28m
- $134.16m
Brief: Kintara Announces One-For-Fifty Reverse Stock Split
Brief: Kintara Therapeutics Announces Fiscal 2023 First Quarter Financial Results
U.S. STOCKS ON THE MOVE-Spirit Airlines, Reata Pharma
U.S. STOCKS ON THE MOVE-Redhill Biopharma, gold miners
U.S. STOCKS ON THE MOVE-BioVie, Intuitive Surgical, Lannett,Zymeworks
Kintara Therapeutics surges on pausing breast cancer trial to conserve cash
Brief: Kintara Therapeutics Pauses Rem-001 Program
Kintara Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Kintara Therapeutics Announces Fiscal 2022 Financial Results And Provides Corporate Update
Kintara Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Kintara Therapeutics Receives Study May Proceed Letter From The FDA For REM-001
Brief: Kintara Therapeutics Inc Files For Common Stock Offering Of Up To $20 Million - SEC Filing
Brief: Kintara Therapeutics Enters Into Equity Purchase Agreement With Lincoln Park Capital
Kintara surges on 'fast track' tag for cancer therapy
Brief: Kintara Therapeutics Granted Fast Track Designation From The FDA For Val-083 For Newly-Diagnosed Glioblastoma
Brief: Kintara Granted 180-Day Extension To Meet Nasdaq Minimum Bid Price Requirement
Kintara Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Kintara Therapeutics Posts Qtrly Net Loss Per Share $0.11
Kintara Therapeutics Inc expected to post a loss of 15 cents a share - Earnings Preview